USA - NASDAQ:DPRX -
The current stock price of DPRX is 1.34 null. In the past month the price increased by 3.08%. In the past year, price decreased by -86.73%.
Dipexium Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops and commercializes Locilex (TM), small peptide topical antibiotic for the treatment of certain mild and moderate skin infections in superficial wounds, including infected decubitus ulcers, infected burns, infected surgical wounds, and nasal colonization of methicillin-resistant staphylococcus aureus. Dipexium Pharmaceuticals, LLC is based in White Plains, New York.
Dipexium Pharmaceuticals Llc
14 WALL ST 3RD FLOOR
NEW YORK NY 10005
CEO: David P. Luci Esq.
Phone: 212-269-2834
The current stock price of DPRX is 1.34 null. The price increased by 3.08% in the last trading session.
The exchange symbol of Dipexium Pharmaceuticals Llc is DPRX and it is listed on the Nasdaq exchange.
DPRX stock is listed on the Nasdaq exchange.
Dipexium Pharmaceuticals Llc (DPRX) has a market capitalization of 15.05M null. This makes DPRX a Nano Cap stock.
Dipexium Pharmaceuticals Llc (DPRX) has a support level at 1.32 and a resistance level at 1.34. Check the full technical report for a detailed analysis of DPRX support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
DPRX does not pay a dividend.
Dipexium Pharmaceuticals Llc (DPRX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.07).
ChartMill assigns a technical rating of 1 / 10 to DPRX. When comparing the yearly performance of all stocks, DPRX is a bad performer in the overall market: 95.05% of all stocks are doing better.
Over the last trailing twelve months DPRX reported a non-GAAP Earnings per Share(EPS) of -2.07. The EPS increased by 75.14% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 100.16% | ||
ROA | -86.72% | ||
ROE | -92.98% | ||
Debt/Equity | 0 |